img

Global Human Coagulation Factor VIII Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Coagulation Factor VIII Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
Human Coagulation Factor VIII report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Human Coagulation Factor VIII market is projected to reach US$ 15770 million in 2034, increasing from US$ 10230 million in 2022, with the CAGR of 6.3% during the period of 2024 to 2034. Demand from Hemophilia A and Spontanous / Trauma are the major drivers for the industry.
Global Human Coagulation Factor VIII key players include Baxter, Bayer, CSL, Pfizer, Biogen, etc. Global top five manufacturers hold a share about 80%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 30 percent. In terms of product, Recombinant Factor VIII is the largest segment, with a share about 65%. And in terms of application, the largest application is Hemophilia A, followed by Spontanous / Trauma, Surgical, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Coagulation Factor VIII market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Shire (Baxter)
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Segment by Type
Recombinant Factor VIII
Plasma-derived Factor VIII

Segment by Application


Hemophilia A
Spontanous / Trauma
Surgical
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Human Coagulation Factor VIII market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Human Coagulation Factor VIII, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Human Coagulation Factor VIII industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Human Coagulation Factor VIII in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Human Coagulation Factor VIII introduction, etc. Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Human Coagulation Factor VIII market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Human Coagulation Factor VIII Market Overview
1.1 Human Coagulation Factor VIII Product Overview
1.2 Human Coagulation Factor VIII Market Segment by Type
1.2.1 Recombinant Factor VIII
1.2.2 Plasma-derived Factor VIII
1.3 Global Human Coagulation Factor VIII Market Size by Type
1.3.1 Global Human Coagulation Factor VIII Market Size Overview by Type (2018-2034)
1.3.2 Global Human Coagulation Factor VIII Historic Market Size Review by Type (2018-2024)
1.3.3 Global Human Coagulation Factor VIII Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Coagulation Factor VIII Sales Breakdown by Type (2018-2024)
1.4.2 Europe Human Coagulation Factor VIII Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Human Coagulation Factor VIII Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Human Coagulation Factor VIII Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Human Coagulation Factor VIII Sales Breakdown by Type (2018-2024)
2 Global Human Coagulation Factor VIII Market Competition by Company
2.1 Global Top Players by Human Coagulation Factor VIII Sales (2018-2024)
2.2 Global Top Players by Human Coagulation Factor VIII Revenue (2018-2024)
2.3 Global Top Players by Human Coagulation Factor VIII Price (2018-2024)
2.4 Global Top Manufacturers Human Coagulation Factor VIII Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Coagulation Factor VIII Market Competitive Situation and Trends
2.5.1 Human Coagulation Factor VIII Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Coagulation Factor VIII Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2022)
2.7 Date of Key Manufacturers Enter into Human Coagulation Factor VIII Market
2.8 Key Manufacturers Human Coagulation Factor VIII Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Coagulation Factor VIII Status and Outlook by Region
3.1 Global Human Coagulation Factor VIII Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Human Coagulation Factor VIII Historic Market Size by Region
3.2.1 Global Human Coagulation Factor VIII Sales in Volume by Region (2018-2024)
3.2.2 Global Human Coagulation Factor VIII Sales in Value by Region (2018-2024)
3.2.3 Global Human Coagulation Factor VIII Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Human Coagulation Factor VIII Forecasted Market Size by Region
3.3.1 Global Human Coagulation Factor VIII Sales in Volume by Region (2024-2034)
3.3.2 Global Human Coagulation Factor VIII Sales in Value by Region (2024-2034)
3.3.3 Global Human Coagulation Factor VIII Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Human Coagulation Factor VIII by Application
4.1 Human Coagulation Factor VIII Market Segment by Application
4.1.1 Hemophilia A
4.1.2 Spontanous / Trauma
4.1.3 Surgical
4.1.4 Other
4.2 Global Human Coagulation Factor VIII Market Size by Application
4.2.1 Global Human Coagulation Factor VIII Market Size Overview by Application (2018-2034)
4.2.2 Global Human Coagulation Factor VIII Historic Market Size Review by Application (2018-2024)
4.2.3 Global Human Coagulation Factor VIII Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Coagulation Factor VIII Sales Breakdown by Application (2018-2024)
4.3.2 Europe Human Coagulation Factor VIII Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Human Coagulation Factor VIII Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Human Coagulation Factor VIII Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Human Coagulation Factor VIII Sales Breakdown by Application (2018-2024)
5 North America Human Coagulation Factor VIII by Country
5.1 North America Human Coagulation Factor VIII Historic Market Size by Country
5.1.1 North America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Human Coagulation Factor VIII Sales in Volume by Country (2018-2024)
5.1.3 North America Human Coagulation Factor VIII Sales in Value by Country (2018-2024)
5.2 North America Human Coagulation Factor VIII Forecasted Market Size by Country
5.2.1 North America Human Coagulation Factor VIII Sales in Volume by Country (2024-2034)
5.2.2 North America Human Coagulation Factor VIII Sales in Value by Country (2024-2034)
6 Europe Human Coagulation Factor VIII by Country
6.1 Europe Human Coagulation Factor VIII Historic Market Size by Country
6.1.1 Europe Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Human Coagulation Factor VIII Sales in Volume by Country (2018-2024)
6.1.3 Europe Human Coagulation Factor VIII Sales in Value by Country (2018-2024)
6.2 Europe Human Coagulation Factor VIII Forecasted Market Size by Country
6.2.1 Europe Human Coagulation Factor VIII Sales in Volume by Country (2024-2034)
6.2.2 Europe Human Coagulation Factor VIII Sales in Value by Country (2024-2034)
7 Asia-Pacific Human Coagulation Factor VIII by Region
7.1 Asia-Pacific Human Coagulation Factor VIII Historic Market Size by Region
7.1.1 Asia-Pacific Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Human Coagulation Factor VIII Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Human Coagulation Factor VIII Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Human Coagulation Factor VIII Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Coagulation Factor VIII Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Human Coagulation Factor VIII Sales in Value by Region (2024-2034)
8 Latin America Human Coagulation Factor VIII by Country
8.1 Latin America Human Coagulation Factor VIII Historic Market Size by Country
8.1.1 Latin America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Human Coagulation Factor VIII Sales in Volume by Country (2018-2024)
8.1.3 Latin America Human Coagulation Factor VIII Sales in Value by Country (2018-2024)
8.2 Latin America Human Coagulation Factor VIII Forecasted Market Size by Country
8.2.1 Latin America Human Coagulation Factor VIII Sales in Volume by Country (2024-2034)
8.2.2 Latin America Human Coagulation Factor VIII Sales in Value by Country (2024-2034)
9 Middle East and Africa Human Coagulation Factor VIII by Country
9.1 Middle East and Africa Human Coagulation Factor VIII Historic Market Size by Country
9.1.1 Middle East and Africa Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Human Coagulation Factor VIII Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Human Coagulation Factor VIII Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Human Coagulation Factor VIII Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Coagulation Factor VIII Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Human Coagulation Factor VIII Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Shire (Baxter)
10.1.1 Shire (Baxter) Company Information
10.1.2 Shire (Baxter) Introduction and Business Overview
10.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Shire (Baxter) Human Coagulation Factor VIII Products Offered
10.1.5 Shire (Baxter) Recent Development
10.2 Bayer
10.2.1 Bayer Company Information
10.2.2 Bayer Introduction and Business Overview
10.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bayer Human Coagulation Factor VIII Products Offered
10.2.5 Bayer Recent Development
10.3 CSL
10.3.1 CSL Company Information
10.3.2 CSL Introduction and Business Overview
10.3.3 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2024)
10.3.4 CSL Human Coagulation Factor VIII Products Offered
10.3.5 CSL Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Pfizer Human Coagulation Factor VIII Products Offered
10.4.5 Pfizer Recent Development
10.5 Grifols
10.5.1 Grifols Company Information
10.5.2 Grifols Introduction and Business Overview
10.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Grifols Human Coagulation Factor VIII Products Offered
10.5.5 Grifols Recent Development
10.6 Biogen
10.6.1 Biogen Company Information
10.6.2 Biogen Introduction and Business Overview
10.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Biogen Human Coagulation Factor VIII Products Offered
10.6.5 Biogen Recent Development
10.7 Octapharma
10.7.1 Octapharma Company Information
10.7.2 Octapharma Introduction and Business Overview
10.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Octapharma Human Coagulation Factor VIII Products Offered
10.7.5 Octapharma Recent Development
10.8 NovoNordisk
10.8.1 NovoNordisk Company Information
10.8.2 NovoNordisk Introduction and Business Overview
10.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2024)
10.8.4 NovoNordisk Human Coagulation Factor VIII Products Offered
10.8.5 NovoNordisk Recent Development
10.9 Greencross
10.9.1 Greencross Company Information
10.9.2 Greencross Introduction and Business Overview
10.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Greencross Human Coagulation Factor VIII Products Offered
10.9.5 Greencross Recent Development
10.10 Kedrion
10.10.1 Kedrion Company Information
10.10.2 Kedrion Introduction and Business Overview
10.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Kedrion Human Coagulation Factor VIII Products Offered
10.10.5 Kedrion Recent Development
10.11 BPL
10.11.1 BPL Company Information
10.11.2 BPL Introduction and Business Overview
10.11.3 BPL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2024)
10.11.4 BPL Human Coagulation Factor VIII Products Offered
10.11.5 BPL Recent Development
10.12 Hualan Bio
10.12.1 Hualan Bio Company Information
10.12.2 Hualan Bio Introduction and Business Overview
10.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Hualan Bio Human Coagulation Factor VIII Products Offered
10.12.5 Hualan Bio Recent Development
10.13 RAAS
10.13.1 RAAS Company Information
10.13.2 RAAS Introduction and Business Overview
10.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2024)
10.13.4 RAAS Human Coagulation Factor VIII Products Offered
10.13.5 RAAS Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Coagulation Factor VIII Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Coagulation Factor VIII Industrial Chain Analysis
11.4 Human Coagulation Factor VIII Market Dynamics
11.4.1 Human Coagulation Factor VIII Industry Trends
11.4.2 Human Coagulation Factor VIII Market Drivers
11.4.3 Human Coagulation Factor VIII Market Challenges
11.4.4 Human Coagulation Factor VIII Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Coagulation Factor VIII Distributors
12.3 Human Coagulation Factor VIII Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Recombinant Factor VIII
Table 2. Major Company of Plasma-derived Factor VIII
Table 3. Global Human Coagulation Factor VIII Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Human Coagulation Factor VIII Sales by Type (2018-2024) & (K Bottles)
Table 5. Global Human Coagulation Factor VIII Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Human Coagulation Factor VIII Sales by Type (2018-2024) & (US& Million)
Table 7. Global Human Coagulation Factor VIII Market Share in Value by Type (2018-2024)
Table 8. Global Human Coagulation Factor VIII Price by Type (2018-2024) & (USD/Bottle)
Table 9. Global Human Coagulation Factor VIII Sales by Type (2024-2034) & (K Bottles)
Table 10. Global Human Coagulation Factor VIII Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Human Coagulation Factor VIII Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Human Coagulation Factor VIII Sales Market Share in Value by Type (2024-2034)
Table 13. Global Human Coagulation Factor VIII Price by Type (2024-2034) & (USD/Bottle)
Table 14. North America Human Coagulation Factor VIII Sales by Type (2018-2024) & (K Bottles)
Table 15. North America Human Coagulation Factor VIII Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Human Coagulation Factor VIII Sales (K Bottles) by Type (2018-2024)
Table 17. Europe Human Coagulation Factor VIII Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Human Coagulation Factor VIII Sales (K Bottles) by Type (2018-2024)
Table 19. Asia-Pacific Human Coagulation Factor VIII Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Human Coagulation Factor VIII Sales (K Bottles) by Type (2018-2024)
Table 21. Latin America Human Coagulation Factor VIII Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Human Coagulation Factor VIII Sales (K Bottles) by Type (2018-2024)
Table 23. Middle East and Africa Human Coagulation Factor VIII Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Human Coagulation Factor VIII Sales by Company (2018-2024) & (K Bottles)
Table 25. Global Human Coagulation Factor VIII Sales Share by Company (2018-2024)
Table 26. Global Human Coagulation Factor VIII Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Human Coagulation Factor VIII Revenue Share by Company (2018-2024)
Table 28. Global Market Human Coagulation Factor VIII Price by Company (2018-2024) & (USD/Bottle)
Table 29. Global Human Coagulation Factor VIII Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Human Coagulation Factor VIII Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2022)
Table 32. Date of Key Manufacturers Enter into Human Coagulation Factor VIII Market
Table 33. Key Manufacturers Human Coagulation Factor VIII Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Human Coagulation Factor VIII Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Human Coagulation Factor VIII Sales by Region (2018-2024) & (K Bottles)
Table 37. Global Human Coagulation Factor VIII Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Human Coagulation Factor VIII Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Human Coagulation Factor VIII Sales Market Share in Value by Region (2018-2024)
Table 40. Global Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 41. Global Human Coagulation Factor VIII Sales by Region (2024-2034) & (K Bottles)
Table 42. Global Human Coagulation Factor VIII Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Human Coagulation Factor VIII Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Human Coagulation Factor VIII Sales Market Share in Value by Region (2024-2034)
Table 45. Global Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2024-2034)
Table 46. Global Human Coagulation Factor VIII Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Human Coagulation Factor VIII Sales by Application (2018-2024) & (K Bottles)
Table 48. Global Human Coagulation Factor VIII Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Human Coagulation Factor VIII Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Human Coagulation Factor VIII Sales Market Share in Value by Application (2018-2024)
Table 51. Global Human Coagulation Factor VIII Price by Application (2018-2024) & (USD/Bottle)
Table 52. Global Human Coagulation Factor VIII Sales by Application (2024-2034) & (K Bottles)
Table 53. Global Human Coagulation Factor VIII Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Human Coagulation Factor VIII Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Human Coagulation Factor VIII Sales Market Share in Value by Application (2024-2034)
Table 56. Global Human Coagulation Factor VIII Price by Application (2024-2034) & (USD/Bottle)
Table 57. North America Human Coagulation Factor VIII Sales by Application (2018-2024) (K Bottles)
Table 58. North America Human Coagulation Factor VIII Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Human Coagulation Factor VIII Sales by Application (2018-2024) (K Bottles)
Table 60. Europe Human Coagulation Factor VIII Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Human Coagulation Factor VIII Sales by Application (2018-2024) (K Bottles)
Table 62. Asia-Pacific Human Coagulation Factor VIII Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Human Coagulation Factor VIII Sales by Application (2018-2024) (K Bottles)
Table 64. Latin America Human Coagulation Factor VIII Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Human Coagulation Factor VIII Sales by Application (2018-2024) (K Bottles)
Table 66. Middle East and Africa Human Coagulation Factor VIII Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Human Coagulation Factor VIII Sales by Country (2018-2024) & (K Bottles)
Table 68. North America Human Coagulation Factor VIII Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Human Coagulation Factor VIII Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Human Coagulation Factor VIII Sales Market Share in Value by Country (2018-2024)
Table 71. North America Human Coagulation Factor VIII Sales by Country (2024-2034) & (K Bottles)
Table 72. North America Human Coagulation Factor VIII Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Human Coagulation Factor VIII Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Human Coagulation Factor VIII Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Human Coagulation Factor VIII Sales by Country (2018-2024) & (K Bottles)
Table 76. Europe Human Coagulation Factor VIII Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Human Coagulation Factor VIII Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Human Coagulation Factor VIII Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Human Coagulation Factor VIII Sales by Country (2024-2034) & (K Bottles)
Table 80. Europe Human Coagulation Factor VIII Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Human Coagulation Factor VIII Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Human Coagulation Factor VIII Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Human Coagulation Factor VIII Sales by Region (2018-2024) & (K Bottles)
Table 84. Asia-Pacific Human Coagulation Factor VIII Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Human Coagulation Factor VIII Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Human Coagulation Factor VIII Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Human Coagulation Factor VIII Sales by Region (2024-2034) & (K Bottles)
Table 88. Asia-Pacific Human Coagulation Factor VIII Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Human Coagulation Factor VIII Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Human Coagulation Factor VIII Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Human Coagulation Factor VIII Sales by Country (2018-2024) & (K Bottles)
Table 92. Latin America Human Coagulation Factor VIII Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Human Coagulation Factor VIII Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Human Coagulation Factor VIII Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Human Coagulation Factor VIII Sales by Country (2024-2034) & (K Bottles)
Table 96. Latin America Human Coagulation Factor VIII Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Human Coagulation Factor VIII Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Human Coagulation Factor VIII Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2018-2024) & (K Bottles)
Table 100. Middle East and Africa Human Coagulation Factor VIII Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Human Coagulation Factor VIII Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2024-2034) & (K Bottles)
Table 104. Middle East and Africa Human Coagulation Factor VIII Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Human Coagulation Factor VIII Sales Market Share in Value by Country (2024-2034)
Table 107. Shire (Baxter) Company Information
Table 108. Shire (Baxter) Introduction and Business Overview
Table 109. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 110. Shire (Baxter) Human Coagulation Factor VIII Product
Table 111. Shire (Baxter) Recent Development
Table 112. Bayer Company Information
Table 113. Bayer Introduction and Business Overview
Table 114. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 115. Bayer Human Coagulation Factor VIII Product
Table 116. Bayer Recent Development
Table 117. CSL Company Information
Table 118. CSL Introduction and Business Overview
Table 119. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 120. CSL Human Coagulation Factor VIII Product
Table 121. CSL Recent Development
Table 122. Pfizer Company Information
Table 123. Pfizer Introduction and Business Overview
Table 124. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 125. Pfizer Human Coagulation Factor VIII Product
Table 126. Pfizer Recent Development
Table 127. Grifols Company Information
Table 128. Grifols Introduction and Business Overview
Table 129. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 130. Grifols Human Coagulation Factor VIII Product
Table 131. Grifols Recent Development
Table 132. Biogen Company Information
Table 133. Biogen Introduction and Business Overview
Table 134. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 135. Biogen Human Coagulation Factor VIII Product
Table 136. Biogen Recent Development
Table 137. Octapharma Company Information
Table 138. Octapharma Introduction and Business Overview
Table 139. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 140. Octapharma Human Coagulation Factor VIII Product
Table 141. Octapharma Recent Development
Table 142. NovoNordisk Company Information
Table 143. NovoNordisk Introduction and Business Overview
Table 144. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 145. NovoNordisk Human Coagulation Factor VIII Product
Table 146. NovoNordisk Recent Development
Table 147. Greencross Company Information
Table 148. Greencross Introduction and Business Overview
Table 149. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 150. Greencross Human Coagulation Factor VIII Product
Table 151. Greencross Recent Development
Table 152. Kedrion Company Information
Table 153. Kedrion Introduction and Business Overview
Table 154. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 155. Kedrion Human Coagulation Factor VIII Product
Table 156. Kedrion Recent Development
Table 157. BPL Company Information
Table 158. BPL Introduction and Business Overview
Table 159. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 160. BPL Human Coagulation Factor VIII Product
Table 161. BPL Recent Development
Table 162. Hualan Bio Company Information
Table 163. Hualan Bio Introduction and Business Overview
Table 164. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 165. Hualan Bio Human Coagulation Factor VIII Product
Table 166. Hualan Bio Recent Development
Table 167. RAAS Company Information
Table 168. RAAS Introduction and Business Overview
Table 169. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 170. RAAS Human Coagulation Factor VIII Product
Table 171. RAAS Recent Development
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Human Coagulation Factor VIII Market Trends
Table 175. Human Coagulation Factor VIII Market Drivers
Table 176. Human Coagulation Factor VIII Market Challenges
Table 177. Human Coagulation Factor VIII Market Restraints
Table 178. Human Coagulation Factor VIII Distributors List
Table 179. Human Coagulation Factor VIII Downstream Customers
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Coagulation Factor VIII Product Picture
Figure 2. Global Human Coagulation Factor VIII Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Human Coagulation Factor VIII Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Human Coagulation Factor VIII Sales Status and Outlook (2018-2034) & (K Bottles)
Figure 5. Product Picture of Recombinant Factor VIII
Figure 6. Global Recombinant Factor VIII Sales YoY Growth (2018-2034) & (K Bottles)
Figure 7. Product Picture of Plasma-derived Factor VIII
Figure 8. Global Plasma-derived Factor VIII Sales YoY Growth (2018-2034) & (K Bottles)
Figure 9. Global Human Coagulation Factor VIII Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Human Coagulation Factor VIII Sales Market Share by Type in 2022 & 2034
Figure 11. North America Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2022
Figure 12. North America Human Coagulation Factor VIII Sales Market Share in Value by Type in 2022
Figure 13. Europe Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2022
Figure 14. Europe Human Coagulation Factor VIII Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Human Coagulation Factor VIII Sales Market Share in Value by Type in 2022
Figure 17. Latin America Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Human Coagulation Factor VIII Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Human Coagulation Factor VIII Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Coagulation Factor VIII Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Coagulation Factor VIII Revenue in 2022
Figure 23. Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hemophilia A
Figure 25. Global Hemophilia A Sales YoY Growth (2018-2034) & (K Bottles)
Figure 26. Product Picture of Spontanous / Trauma
Figure 27. Global Spontanous / Trauma Sales YoY Growth (2018-2034) & (K Bottles)
Figure 28. Product Picture of Surgical
Figure 29. Global Surgical Sales YoY Growth (2018-2034) & (K Bottles)
Figure 30. Product Picture of Other
Figure 31. Global Other Sales YoY Growth (2018-2034) & (K Bottles)
Figure 32. Global Human Coagulation Factor VIII Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Human Coagulation Factor VIII Sales Market Share by Application in 2022 & 2034
Figure 34. North America Human Coagulation Factor VIII Sales Market Share in Volume by Application in 2022
Figure 35. North America Human Coagulation Factor VIII Sales Market Share in Value by Application in 2022
Figure 36. Europe Human Coagulation Factor VIII Sales Market Share in Volume by Application in 2022
Figure 37. Europe Human Coagulation Factor VIII Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Human Coagulation Factor VIII Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Human Coagulation Factor VIII Sales Market Share in Value by Application in 2022
Figure 40. Latin America Human Coagulation Factor VIII Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Human Coagulation Factor VIII Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Human Coagulation Factor VIII Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Human Coagulation Factor VIII Manufacturing Cost Structure
Figure 45. Human Coagulation Factor VIII Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries